Deepak Shenoy at Capital Mind has done a nice review of the Adlabs Imagica IPO
But I found his disclaimer even better than the review:
Very important note: Look, we’re in a bull market. Any share can go up. In 2006, We didn’t like the GMR IPO issue. It went from 250 to 800. We looked like fools. Then after a 10:1 split the price is now less than Rs. 18 (which would be Rs. 180 for the 2006 IPO holders). That makes us look better. But remember, the price went 4x before it fell – anything can happen, don’t just trust us. We have effectively ditched a potential 4x return earlier. That’s our disclaimer.
2 replies on “Disclaimer”
Sir is Kilitch Drug a classic case of undervaluation as performancewise its profits and turnover has already doubled compared to LY within 9 months of CY, it has cash bal of Rs30/-share and reserves of more than 100cr. company did well between 2008 to 2011 and then sold its few plants to multinational and paid 300% spl div to shareholders in 2012 now since last few quarters growth is also good also no debt no pledge promoter stake 65% with good management so then why stock should be at 35 when markets in bull run? have i missed some aspect pls guide and can it atlst appreciate to one third value of Anuh pharma. can i buy it now ?
Regret we do not offer investment advice.